Nomos expands uses for cancer technology:
This article was originally published in Clinica
North American Scientific's radiation oncology division Nomos has launched an image-guided tracking feature that expands the clinical applications for its BAT (B-mode acquisition and targeting) image-guided radiation therapy technology. The new optical camera targeting solution widens BAT's current clinical use in the prostate to applications in the breast, liver, pancreas, bladder, cervix and head and neck. Coupled with the optical camera, is a patented ultrasound probe tracker that will allow the user to navigate on multiple planes and at multiple angles. Both features enable clinicians using BAT to locate soft tissue targets anywhere in the body, quickly and easily, said the Chatsworth, California firm.
You may also be interested in...
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.
Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.